US Healthcare Biometrics Market

ID: MRFR/HCIT/17127-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Healthcare Biometrics Market Research Report: Size, Share, Trend Analysis By Technology (Fingerprint Recognition, Iris Recognition, Facial Recognition, Voice Recognition, Vein Recognition), By Applications (Patient Identification, Access Control, Billing and Payments, Electronic Health Records, Telemedicine), By End Use (Hospitals, Clinics, Diagnostic Centers, Pharmaceutical Companies, Research Institutions) and By Deployment (On-Premise, Cloud-Based, Hybrid) - Growth Outlook & Industry Forecast 2025 To 2035
US Healthcare Biometrics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)21.89%
2024 Market Size$ 8.5 Billion
2025 Market Size$ 10.36 Billion
2035 Market Size$ 75 Billion
Key Players
Cerner Corporation
Philips Healthcare
Siemens Healthineers
GE Healthcare
Medtronic
Honeywell
Trends
  • Increased Adoption of Biometric Authentication
  • Integration with Electronic Health Records (EHR)
  • Focus on Regulatory Compliance
Opportunities
  • Rising Demand for Enhanced Security
  • Growing Emphasis on Patient Experience
  • Regulatory Support for Biometric Implementation
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Technology (USD Billion)
      1. 4.1.1 Fingerprint Recognition
      2. 4.1.2 Iris Recognition
      3. 4.1.3 Facial Recognition
      4. 4.1.4 Voice Recognition
      5. 4.1.5 Vein Recognition
    2. 4.2 Pharmaceutical, BY Application (USD Billion)
      1. 4.2.1 Patient Identification
      2. 4.2.2 Access Control
      3. 4.2.3 Billing and Payments
      4. 4.2.4 Electronic Health Records
      5. 4.2.5 Telemedicine
    3. 4.3 Pharmaceutical, BY Use (USD Billion)
      1. 4.3.1 Hospitals
      2. 4.3.2 Clinics
      3. 4.3.3 Diagnostic Centers
      4. 4.3.4 Pharmaceutical Companies
      5. 4.3.5 Research Institutions
    4. 4.4 Pharmaceutical, BY Deployment (USD Billion)
      1. 4.4.1 On-Premise
      2. 4.4.2 Cloud-Based
      3. 4.4.3 Hybrid
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cerner Corporation (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Philips Healthcare (NL)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GE Healthcare (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medtronic (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Honeywell (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 3M Company (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Fujitsu (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 NantHealth (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
      10. 5.2.10 NextGen Healthcare (US)
        1. 5.2.10.1 Financial Overview
        2. 5.2.10.2 Products Offered
        3. 5.2.10.3 Key Developments
        4. 5.2.10.4 SWOT Analysis
        5. 5.2.10.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
    3. 6.3 US MARKET ANALYSIS BY APPLICATION
    4. 6.4 US MARKET ANALYSIS BY USE
    5. 6.5 US MARKET ANALYSIS BY DEPLOYMENT
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY USE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY USE, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY DEPLOYMENT, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY DEPLOYMENT, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY USE, 2025-2035 (USD Billion)
      4. 7.2.4 BY DEPLOYMENT, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Healthcare Biometrics Market Segmentation

US Healthcare Biometrics Market By Technology (USD Billion, 2025-2035)

  • Fingerprint Recognition
  • Iris Recognition
  • Facial Recognition
  • Voice Recognition
  • Vein Recognition

US Healthcare Biometrics Market By Application (USD Billion, 2025-2035)

  • Patient Identification
  • Access Control
  • Billing and Payments
  • Electronic Health Records
  • Telemedicine

US Healthcare Biometrics Market By Use (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • US Healthcare Biometrics Market Companies
  • Research Institutions

US Healthcare Biometrics Market By Deployment (USD Billion, 2025-2035)

  • On-Premise
  • Cloud-Based
  • Hybrid

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.